JOHNSON & JOHNSON | Johnson & Johnson | Tennessee | local | 2013 | $11,337 | | property tax abatement |
JOHNSON & JOHNSON HEALTH CARE SYSTEMS INC | Johnson & Johnson | Tennessee | local | 2013 | $2,584 | | property tax abatement |
JOHNSON & JOHNSON HEALTH CARE SYSTEMS INC | Johnson & Johnson | Tennessee | local | 2013 | $4,837 | | property tax abatement |
JOHNSON & JOHNSON HEALTH CARE SYSTEMS INC | Johnson & Johnson | Tennessee | local | 2013 | $45,482 | | property tax abatement |
PFIZER INC | Pfizer | Tennessee | local | 2013 | $12,319 | | property tax abatement |
PFIZER INC | Pfizer | Tennessee | local | 2013 | $15,136 | | property tax abatement |
JOHNSON & JOHNSON | Johnson & Johnson | Tennessee | local | 2011 | $10,397 | | property tax abatement |
JOHNSON & JOHNSON | Johnson & Johnson | Tennessee | local | 2011 | $11,320 | | property tax abatement |
JOHNSON & JOHNSON | Johnson & Johnson | Tennessee | local | 2011 | $19,119 | | property tax abatement |
JOHNSON & JOHNSON HEALTH CARE SYSTEMS INC | Johnson & Johnson | Tennessee | local | 2011 | $2,980 | | property tax abatement |
JOHNSON & JOHNSON HEALTH CARE SYSTEMS INC | Johnson & Johnson | Tennessee | local | 2011 | $6,498 | | property tax abatement |
JOHNSON & JOHNSON HEALTH CARE SYSTEMS INC | Johnson & Johnson | Tennessee | local | 2011 | $21,226 | | property tax abatement |
PFIZER INC | Pfizer | Tennessee | local | 2011 | $3,278 | | property tax abatement |
PFIZER INC | Pfizer | Tennessee | local | 2011 | $57,012 | | property tax abatement |
PFIZER, INC | Pfizer | Tennessee | local | 2011 | $2,666 | | property tax abatement |
PFIZER, INC | Pfizer | Tennessee | local | 2011 | $7,292 | | property tax abatement |
JOHNSON & JOHNSON (UNDER MEMPHIS TRADE) | Johnson & Johnson | Tennessee | local | 2013 | $195,430 | | property tax abatement |
JOHNSON & JOHNSON HEALTH CARE | Johnson & Johnson | Tennessee | local | 2013 | $61,809 | | property tax abatement |
Johnson & Johnson Health Care Systems | Johnson & Johnson | Tennessee | local | 2014 | undisclosed | | property tax abatement |
Pfizer, Inc. | Pfizer | Tennessee | local | 2014 | undisclosed | | property tax abatement |
Pfizer, Inc. | Pfizer | Tennessee | local | 2014 | undisclosed | | property tax abatement |
Pfizer, Inc. | Pfizer | Tennessee | local | 2014 | undisclosed | | property tax abatement |
Pfizer, Inc. | Pfizer | Tennessee | local | 2014 | undisclosed | | property tax abatement |
JOHNSON & JOHNSON HEALTH CARE SYSTEMS INC | Johnson & Johnson | Tennessee | local | 2014 | $2,578 | | property tax abatement |
PFIZER, INC | Pfizer | Tennessee | local | 2014 | $3,011 | | property tax abatement |
JOHNSON & JOHNSON HEALTH CARE SYSTEMS INC | Johnson & Johnson | Tennessee | local | 2014 | $4,377 | | property tax abatement |
JOHNSON & JOHNSON HEALTH CARE SYSTEMS INC | Johnson & Johnson | Tennessee | local | 2014 | $11,311 | | property tax abatement |
JOHNSON & JOHNSON HEALTH CARE SYSTEMS INC | Johnson & Johnson | Tennessee | local | 2014 | $11,532 | | property tax abatement |
JOHNSON & JOHNSON | Johnson & Johnson | Tennessee | local | 2014 | $12,315 | | property tax abatement |
JOHNSON & JOHNSON HEALTH CARE SYSTEMS INC | Johnson & Johnson | Tennessee | local | 2014 | $37,127 | | property tax abatement |
Johnson & Johnson Health Care Systems | Johnson & Johnson | Tennessee | local | 2016 | undisclosed | | property tax abatement |
Pfizer, Inc. | Pfizer | Tennessee | local | 2016 | undisclosed | | property tax abatement |
Pfizer, Inc. | Pfizer | Tennessee | local | 2017 | $2,582,313 | | property tax abatement |
JOHNSON & JOHNSON HEALTH CARE SYSTEMS | Johnson & Johnson | Tennessee | local | 2017 | undisclosed | | property tax abatement |
PFIZER, INC. | Pfizer | Tennessee | local | 2017 | undisclosed | | property tax abatement |
PFIZER | Pfizer | Tennessee | Local | 2020 | undisclosed | | property tax abatement |
PFIZER | Pfizer | Tennessee | Local | 2020 | undisclosed | | property tax abatement |
Pfizer | Pfizer | Tennessee | state | 2021 | undisclosed | | property tax abatement |
Pfizer | Pfizer | Tennessee | state | 2021 | undisclosed | | property tax abatement |
Pfizer | Pfizer | Tennessee | state | 2021 | undisclosed | | property tax abatement |
Pfizer | Pfizer | Tennessee | state | 2022 | undisclosed | | property tax abatement |
Pfizer | Pfizer | Tennessee | state | 2022 | undisclosed | | property tax abatement |
Pfizer | Pfizer | Tennessee | state | 2022 | undisclosed | | property tax abatement |
Pacesetter, Inc. (St. Jude Medical) | Abbott Laboratories | South Carolina | state | 2009 | undisclosed | | tax credit/rebate |
Roche Carolina Inc. | Roche | South Carolina | state | 2009 | undisclosed | | tax credit/rebate |
St. Jude Medical | Abbott Laboratories | South Carolina | state | 2006 | undisclosed | | tax credit/rebate |
Roche Carolina, Inc. | Roche | South Carolina | state | 2006 | undisclosed | | tax credit/rebate |
BAUSH & LOMB | Bausch Health | South Carolina | state | 2010 | $615,965 | | training reimbursement |
ST. JUDE MEDICAL | Abbott Laboratories | South Carolina | state | 2009 | $59,305 | | training reimbursement |
St. Jude Medical Cardiology Division, Inc. | Abbott Laboratories | South Carolina | state | 2018 | undisclosed | | tax credit/rebate |
Alcami Carolinas Corporation | Alcami | South Carolina | state | 2022 | undisclosed | | grant |
Immunex Rhode Island Corp. | Amgen | Rhode Island | state | 2013 | $258,315 | | tax credit/rebate |
Alexion Pharmaceuticals | AstraZeneca | Rhode Island | state | 2013 | undisclosed | | tax credit/rebate |
Immunex Rhode Island Corp. | Amgen | Rhode Island | state | 2015 | $56,783 | | tax credit/rebate |
Immunex RI Corporation | Amgen | Rhode Island | state | 2018 | $6,000,000 | | tax credit/rebate |
Immunex RI Corporation | Amgen | Rhode Island | state | 2018 | $3,450,000 | | tax credit/rebate |
Immunex RI Corporation | Amgen | Rhode Island | state | 2018 | $3,255,000 | | tax credit/rebate |
Centocor, Inc. | Johnson & Johnson | Pennsylvania | state | | $1,000,000 | | training reimbursement |
Merck & Co., Inc. | Merck | Pennsylvania | state | | $735,000 | | training reimbursement |
Aventis Pasteur USA | Sanofi | Pennsylvania | state | | $509,900 | | training reimbursement |
GlaxoSmithKline Biologicals North America | GlaxoSmithKline | Pennsylvania | state | | $316,181 | | training reimbursement |
Merck & Co., Inc. | Merck | Pennsylvania | state | | $265,000 | | training reimbursement |
BioRexis | Pfizer | Pennsylvania | state | | $250,000 | | training reimbursement |
GlaxoSmithKline | GlaxoSmithKline | Pennsylvania | state | | $200,000 | | training reimbursement |
Johnson & Johnson Merck Consumer Pharmaceuticals | Johnson & Johnson | Pennsylvania | state | | $160,000 | | training reimbursement |
TEVA Pharmaceuticals USA | Teva Pharmaceutical Industries | Pennsylvania | state | | $150,000 | | training reimbursement |
Ventana USA | Roche | Pennsylvania | state | | $28,836 | | training reimbursement |
Wyeth-Ayerst Pharmaceuticals | Pfizer | Pennsylvania | state | | $500,000 | | grant |
Aventis Pasteur USA | Sanofi | Pennsylvania | state | | $500,000 | | grant |
Centocor, Inc. | Johnson & Johnson | Pennsylvania | state | | $3,000,000 | | tax credit/rebate |
Cephalon, Inc. | Teva Pharmaceutical Industries | Pennsylvania | state | | $1,749,000 | | tax credit/rebate |
GlaxoSmithKline Biologicals North America dba Corixa | GlaxoSmithKline | Pennsylvania | state | | $1,350,000 | | tax credit/rebate |
Shire Pharmaceuticals, Inc. | Takeda Pharmaceutical | Pennsylvania | state | | $1,200,000 | | tax credit/rebate |
Mutual Pharmaceutical Company, Inc. | Sun Pharmaceuticals | Pennsylvania | state | | $975,000 | | tax credit/rebate |
Aventis Pasteur Inc. | Sanofi | Pennsylvania | state | | $810,000 | | tax credit/rebate |
Cherokee Pharmaceuticals, LLC | Merck | Pennsylvania | state | | $699,000 | | tax credit/rebate |
C3i Incorporated | Merck | Pennsylvania | state | | $458,000 | | tax credit/rebate |
Mylan Inc. | Viatris | Pennsylvania | state | | $450,000 | | tax credit/rebate |
Teva Pharmaceuticals USA, Inc. | Teva Pharmaceutical Industries | Pennsylvania | state | | $405,000 | | tax credit/rebate |
Teva Pharmaceuticals USA, Inc. | Teva Pharmaceutical Industries | Pennsylvania | state | | $345,000 | | tax credit/rebate |
CSL Behring LLC | CSL Limited | Pennsylvania | state | | $126,000 | | tax credit/rebate |
Auxillum Pharmaceuticals, Inc. | Endo International | Pennsylvania | state | | $120,000 | | tax credit/rebate |
Chiron Corporation | Novartis | Pennsylvania | state | | $60,000 | | tax credit/rebate |
Ventana USA | Roche | Pennsylvania | state | | $25,000 | | tax credit/rebate |
Vitae Pharmaceuticals, Inc | AbbVie | Pennsylvania | state | | $10,000 | | tax credit/rebate |
Cherokee Pharmaceuticals, LLC | Merck | Pennsylvania | state | | | $5,000,000 | loan or bond financing |
Trevena, Inc. | Trevena Inc. | Pennsylvania | state | | | $815,278 | loan or bond financing |
Lannett Company, Inc. | Lannett Co. | Pennsylvania | state | | | $500,000 | loan or bond financing |
Novavax, Inc. | Novavax Inc. | Pennsylvania | state | | | $500,000 | loan or bond financing |
Morphotek Inc. | Eisai | Pennsylvania | state | | | $200,000 | loan or bond financing |
Cephalon, Inc. | Teva Pharmaceutical Industries | Pennsylvania | state | | $4,000,000 | | grant |
Centocor, Inc. | Johnson & Johnson | Pennsylvania | state | | $2,000,000 | | grant |
Shire Pharmaceuticals, Inc. | Takeda Pharmaceutical | Pennsylvania | state | | $2,000,000 | | grant |
GlaxoSmithKline Biologicals North America dba Corixa | GlaxoSmithKline | Pennsylvania | state | | $1,350,000 | | grant |
Merck & Co., Inc. | Merck | Pennsylvania | state | | $1,200,000 | | grant |
Cherokee Pharmaceuticals, LLC | Merck | Pennsylvania | state | | $1,200,000 | | grant |
Aventis Pasteur Inc. | Sanofi | Pennsylvania | state | | $1,000,000 | | grant |
Mutual Pharmaceutical Company, Inc. | Sun Pharmaceuticals | Pennsylvania | state | | $650,000 | | grant |
Mylan Inc. | Viatris | Pennsylvania | state | | $600,000 | | grant |
Wyeth Pharmaceuticals, Inc. | Pfizer | Pennsylvania | state | | $500,000 | | grant |
Lannett Company, Inc. | Lannett Co. | Pennsylvania | state | | $500,000 | | grant |